Assessing the anesthetic effectiveness of remimazolam in MELAS patients requires careful investigations

被引:0
|
作者
Josef Finsterer
机构
[1] Neurology & Neurophysiology Center,
来源
JA Clinical Reports | / 8卷
关键词
COVID-19; SARS-CoV-2; Neuroimmunology; Anxiety; Depression;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Assessing the anesthetic effectiveness of remimazolam in MELAS patients requires careful investigations
    Finsterer, Josef
    JA CLINICAL REPORTS, 2022, 8 (01)
  • [2] An anesthetic experience with remimazolam for MELAS patients
    Atsuhiro Kitaura
    Shinichi Nakao
    JA Clinical Reports, 8
  • [3] An anesthetic experience with remimazolam for MELAS patients
    Kitaura, Atsuhiro
    Nakao, Shinichi
    JA CLINICAL REPORTS, 2022, 8 (01)
  • [4] Assessing the harms of polypharmacy requires careful interpretation and consistent definitions
    Kouladjian, Lisa
    Hilmer, Sarah N.
    Chen, Timothy F.
    Le Couteur, David G.
    Gnjidic, Danijela
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 78 (03) : 670 - 671
  • [5] Benefits of remimazolam as an anesthetic sedative for older patients: A review
    Jin, Ning
    Xue, Zhiqiang
    HELIYON, 2024, 10 (04)
  • [6] Response to: Assessing the harms of polypharmacy requires careful interpretation and consistent definitions
    Payne, Rupert A.
    Abel, Gary A.
    Avery, Anthony J.
    Mercer, Stewart W.
    Roland, Martin O.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 78 (03) : 672 - 673
  • [7] Assessing the effect of oral glutamine on the MELAS phenotype requires appropriate study designs
    Finsterer, Josef
    NEURORADIOLOGY, 2024, 66 (04) : 459 - 460
  • [8] Assessing the effect of oral glutamine on the MELAS phenotype requires appropriate study designs
    Josef Finsterer
    Neuroradiology, 2024, 66 : 459 - 460
  • [9] Reply: assessing the effect of oral glutamine on the MELAS phenotype requires appropriate study designs
    Paz Guerrero-Molina, Maria
    Gonzalez de la Aleja, Jesus
    NEURORADIOLOGY, 2024, 66 (04) : 461 - 462
  • [10] Reply: assessing the effect of oral glutamine on the MELAS phenotype requires appropriate study designs
    María Paz Guerrero-Molina
    Jesús González de la Aleja
    Neuroradiology, 2024, 66 : 461 - 462